AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic MedCity News
Category: GLP-1 News
LEMME TELL YOU| No shoes on at home; Secret weight loss; Cruise controversy – Fox Baltimore
LEMME TELL YOU| No shoes on at home; Secret weight loss; Cruise controversy Fox Baltimore
Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians – Telehealth.org | Professional Training & Consultation
Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians Telehealth.org | Professional Training…
Using artificial intelligence to enhance regenerative medicine
As the field of regenerative medicine continues to advance, the incorporation of AI is playing a…
Using artificial intelligence to enhance regenerative medicine
As the field of regenerative medicine continues to advance, the incorporation of AI is playing a…
AbbVie gets into obesity with $350M deal for once-weekly shot – BioPharma Dive
AbbVie gets into obesity with $350M deal for once-weekly shot BioPharma Dive
Novo Nordisk and AI-driven Gensaic enter into $354m cardiometabolic deal
Novo Nordisk and AI-driven protein design company Gensaic are to develop tissue-targeted therapies for cardiometabolic diseases.
How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments – Medical Xpress
How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments Medical…
Weight loss stalled? Scientists may have figured out a way to trick metabolism into speeding up – New York Post
Weight loss stalled? Scientists may have figured out a way to trick metabolism into speeding up New…
Tackling nutrient deficiencies is key to long-term weight loss success, says nutrition expert – Nutraceutical Business Review
Tackling nutrient deficiencies is key to long-term weight loss success, says nutrition expert Nutraceutical Business Review